journal
MENU ▼
Read by QxMD icon Read
search

Canadian Journal of Hospital Pharmacy

journal
https://read.qxmd.com/read/30626989/to-err-is-human-%C3%A2
#1
Douglas Doucette
No abstract text is available yet for this article.
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626988/l%C3%A2-erreur-est-humaine%C3%A2
#2
Douglas Doucette
No abstract text is available yet for this article.
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626987/should-emergency-pharmacists-focus-on-providing-care-to-admitted-patients-rather-than-non-admitted-patients
#3
(no author information available yet)
No abstract text is available yet for this article.
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626986/propofol-induced-green-breast-milk-a-case-report
#4
Anthony Rainone, Laura Delucilla, Stéphanie Elofer, Leah Bensimon, Gaëlle Abittan
No abstract text is available yet for this article.
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626985/safety-rounds-a-patient-safety-initiative
#5
Heather Kertland, Salma Satchu, Clarence Chant, Jill Garland, Elaine Tom
No abstract text is available yet for this article.
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626984/analyse-des-modes-de-d%C3%A3-faillance-de-leurs-effets-et-de-leur-criticit%C3%A3-dans-le-circuit-du-m%C3%A3-dicament-revue-de-litt%C3%A3-rature
#6
Émile Demers, Laurence Collin-Lévesque, Marianne Boulé, Sophie Lachapelle, Christina Nguyen, Denis Lebel, Jean-François Bussières
Background: Failure mode, effects, and criticality analysis (FMECA) is a systematic and proactive risk analysis method to determine major failures in complex processes. Objective: To identify all articles involving the use of failure mode and effects analysis (FMEA), FMECA, or FMECA in health care within the medication use system. Data Sources Study Selection and Data Extraction: The MEDLINE database was searched, for the period January 1990 to January 2017...
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626983/risk-evaluation-for-antipsychotic-agents-used-in-elderly-inpatients-repair
#7
Flora Yu, Reza Rafizadeh, Vincent H Mabasa, Nirmal Kang
Background: Antipsychotics have been approved for the treatment of certain psychiatric illnesses. However, these medications are also frequently used off label, and recent studies have suggested a concerning potential increase in the risk of death when used by elderly patients with dementia. Most of the available literature focusing on off-label use of antipsychotics comes from long-term care facilities; there is a lack of quantitative data for elderly patients in the acute care setting...
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626982/safety-of-rectal-administration-of-acetaminophen-in-neonates
#8
Lori Chen, Monica Zhang, Jason Yung, Jennifer Chen, Carol McNair, Kyong-Soon Lee
Background: On the basis of pharmacokinetic modelling, high-dose acetaminophen by rectal administration has been recommended for neonates needing antipyretic or analgesic therapy, but the safety and efficacy of this approach have not been established in vivo. Objectives: The primary objective was to assess the safety of rectal acetaminophen administration for neonates, as indicated by changes in the results of hepatic and renal function tests. The secondary objective was to assess the efficacy of rectal acetaminophen administration in terms of the Premature Infant Pain Profile-Revised (PIPP-R) score...
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626981/evaluation-of-collaborative-medication-reviews-for-high-risk-older-adults
#9
Winnie W T Chan, Karen Dahri, Nilufar Partovi, Gregory Egan, Vandad Yousefi
Background: Despite the widespread use of medication reviews, many older adults are still exposed to the risks of polypharmacy. Objectives: To quantify and describe the drug therapy problems identified and interventions undertaken by pharmacists before and after implementation (on July 1, 2015) of collaborative medication review for high-risk older adult patients (> 80 years of age). Methods: A retrospective single-centre pre-post cohort study was conducted between July 1, 2014, and July 31, 2016, to characterize the impact of collaborative medication reviews-consisting of a thorough medication review by a pharmacist and care conferences with the hospitalist and family physician-on prescribing patterns in an Acute Care for Elders unit...
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626980/ticagrelor-and-acetylsalicylic-acid-after-placement-of-pipeline-embolization-device-for-cerebral-aneurysm-a-case-series
#10
Jodi R DeGrote, Elizabeth M Olafson, Alexander Drofa, Evgueni Kouznetzov, Michael Manchak, Nathan D Leedahl, David D Leedahl
Background: Dual antiplatelet therapy with acetylsalicylic acid (ASA) and a P2Y12-receptor antagonist is often used to prevent thrombotic complications after placement of a Pipeline embolization device (PED) for cerebral aneurysm. Although clopidogrel is common in this setting, high rates of nonresponse to this drug have made ticagrelor a potentially attractive alternative. Objective: To describe safety and efficacy outcomes for ticagrelor following PED placement, including measurement of platelet function...
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626979/l%C3%A2-importance-des-observations-cliniques
#11
EDITORIAL
Cynthia Jackevicius
No abstract text is available yet for this article.
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30626978/the-value-of-case-reports
#12
EDITORIAL
Cynthia Jackevicius
No abstract text is available yet for this article.
November 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30402002/evaluating-priorities-and-resources-a-balancing-act
#13
Tania Mysak
No abstract text is available yet for this article.
September 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30402001/%C3%A3-valuer-les-priorit%C3%A3-s-et-les-ressources-un-exercice-d%C3%A2-%C3%A3-quilibre
#14
Tania Mysak
No abstract text is available yet for this article.
September 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30402000/is-it-necessary-for-pharmacists-to-evaluate-other-health-professionals-satisfaction-with-pharmacist-services
#15
(no author information available yet)
No abstract text is available yet for this article.
September 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30401999/roles-and-impacts-of-the-transplant-pharmacist-a-systematic-review
#16
REVIEW
Sébastien Sam, Aurélie Guérin, André Rieutord, Stéphanie Belaiche, Jean-François Bussières
Background: Pharmacists have been involved in the care of transplant recipients for several decades, and a growing body of literature shows the beneficial effects of clinical pharmacist care on important outcomes for these patients. Objectives: The primary objective was to describe the roles and impacts of pharmacists in a solid organ transplant setting. The secondary objective was to describe and rate the pharmacists' interventions. Data Sources: Three databases-PubMed, Embase, and Evidence-Based Medicine Reviews-were searched from January 1, 1990, to June 16, 2015...
September 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30401998/characterization-of-serious-adverse-drug-reactions-in-hospital-to-determine-potential-implications-of-mandatory-reporting
#17
Stephanie Gautron, Jason Wentzell, Salmaan Kanji, Tiffany Nguyen, Daniel M Kobewka, Erika MacDonald
Background: The Protecting Canadians from Unsafe Drugs Act will eventually require institutions to report all serious adverse drug reactions (ADRs), although the proposed regulations do not yet define what will need to be reported and by whom. Knowledge about the occurrence of serious ADRs in the hospital setting is needed to optimize the effectiveness of reporting and to determine the potential implications of mandatory reporting. Objectives: To quantify and characterize suspected serious ADRs in patients admitted to a general medicine service, to assess the likelihood of causality, and to determine inter-rater agreement for identification of ADRs and assessment of their likelihood...
September 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30401997/evaluation-of-prescribing-appropriateness-and-initiatives-to-improve-prescribing-of-proton-pump-inhibitors-at-vancouver-general-hospital
#18
Andrea Wan, Katelyn Halpape, Shirin C Talkhi, Claire Dixon, Hafeez Dossa, Jenifer Tabamo, Mark Roberts, Karen Dahri
Background: Proton pump inhibitors (PPIs) have proven clinical efficacy for a variety of indications. However, there is emerging evidence of adverse events associated with their long-term use. The emergence of these adverse events has reinforced the need to regularly evaluate the appropriateness of continuing PPI therapy, and to use only the lowest effective dose for the minimally indicated duration. Objectives: To characterize the appropriateness of PPI orders continued or initiated in the internal medicine and family practice units of Vancouver General Hospital, to detect adverse events associated with PPI use, and to explore the impact of multidisciplinary teaching and provision of educational resources on health care practitioners' views about PPI use...
September 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30401996/quantifying-candidacy-for-deprescribing-of-proton-pump-inhibitors-among-long-term-care-residents
#19
Alanna Doell, Ashley Walus, Jaclyn To, Allison Bell
Background: Proton pump inhibitors (PPIs) are a commonly prescribed drug class used to inhibit gastric acid secretion. They are prescribed for both treatment and prophylaxis of several gastrointestinal conditions. Although PPIs can be used safely in the short term, several serious adverse effects have been reported following long-term use, including increased risk of falls and fragility fractures. Long-term care home (LTCH) residents represent a population in which the long-term adverse effects of PPIs can be significant and PPI deprescribing should be considered when appropriate...
September 2018: Canadian Journal of Hospital Pharmacy
https://read.qxmd.com/read/30401995/is-there-a-reason-for-the-proton-pump-inhibitor-an-assessment-of-prescribing-for-residential-care-patients-in-british-columbia
#20
Adriel Chan, Libby Liang, Anthony C H Tung, Angus Kinkade, Aaron M Tejani
Background: The use of proton pump inhibitors (PPIs) may cause significant harm to patients in the residential care setting, as these patients are often frail with multiple morbidities. The extent of non-evidence-based use of PPIs in residential care sites of the Fraser Health Authority in British Columbia is unknown. Objective: To determine the proportion of non-evidence-based use of PPI therapy for residential care patients of the Fraser Health Authority. Methods: This retrospective cross-sectional study was conducted in 6 Fraser Health residential care facilities in British Columbia between April 1, 2015, and March 31, 2016...
September 2018: Canadian Journal of Hospital Pharmacy
journal
journal
22254
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"